Diagnostic technologies are commercially available to measure human blood volume. A recent radionucleotide study called BVA-100, Blood Volume Analysis is the only FDA approved instrument that provides a measure of Red Blood Cells and Plasma with 98% accuracy.
Blood volume measurement is indicated for the diagnosis and treatment patients suffering from Congestive Heart Failure, Chronic Hypertension, Renal Failure and Critical Care.
Agency Reviews Patent Application Approval Request for "Apparatus and Method for Orthogonalizing Signals Detecting Blood Oxygenation and Blood Volume"
Nov 20, 2012; By a News Reporter-Staff News Editor at Life Science Weekly -- A patent application by the inventors Barber, Timothy P. (Boise,...
Society of Critical Care Medicine Conference in Houston Has 3 Research Studies Presented Involving the Daxor BVA-100 Blood Volume Analyzer
Feb 27, 2012; The annual Society of Critical Care Medicine Conference, attended by over 1,000 participants, was held in Houston, Texas from...